Moksha8, a Brazil-based specialty drugs company, raises $61m in its series D round that includes Watson Pharmaceuticals.

New York-listed drugs company Watson Pharmaceuticals has provided at least half of Moksha8’s, a Brazil-based specialty pharmaceuticals company, fourth round of funding.

Watson has agreed to invest $30m for a minority stake in Moksha8 and a marketing agreement to access Brazil and Mexico. Watson has also agreed to take a board seat at Moksha8 and invest a further $20m for an increased equity stake if the portfolio company can agree third-party acquisitions.

Excluding this contingent acquisition fund, Moksha8 raised $61m…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?